Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $91 | $49 | $37 | $62 |
| - Cash | $17 | $9 | $8 | $16 |
| + Debt | $3 | $0 | $0 | $0 |
| Enterprise Value | $77 | $40 | $28 | $46 |
| Revenue | $5 | $10 | $5 | $4 |
| % Growth | -44.7% | 103.2% | 34.3% | – |
| Gross Profit | $5 | $10 | $4 | $3 |
| % Margin | 100% | 100% | 91.7% | 89% |
| EBITDA | -$15 | -$13 | -$15 | -$13 |
| % Margin | -273.5% | -130.1% | -311.3% | -349.4% |
| Net Income | -$15 | -$13 | -$11 | -$9 |
| % Margin | -268.4% | -131.3% | -220% | -260.9% |
| EPS Diluted | -0.005 | -0.006 | -0.006 | -0.005 |
| % Growth | 18.3% | -5.3% | -7.5% | – |
| Operating Cash Flow | -$8 | -$17 | -$9 | -$10 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$8 | -$17 | -$9 | -$10 |